Through his role on the House Judiciary Subcommittee on Antitrust, Commercial and Administrative Law, Congressman Neguse has played a leading role in advocating for proper antitrust enforcement. As part of the Subcommittee's investigation into anti-competitive behaviors in the digital marketplace, Congressman Neguse brought the Committee to Boulder, Colorado for a field hearing in January 2019. In the 116th Congress, Neguse introduced and enacted two antitrust enforcement measures into law, which would protect antitrust whistleblowers and reauthorize a critical antitrust enforcement program. Following the conclusion of the Subcommittee’s big tech investigation, Congressman Neguse has called for a similar investigation into Big Pharma, in particular an examination of the FTC’s oversight of mergers for the pharmaceutical industry.
Congressman Neguse has enacted the following laws:
Antitrust Criminal Penalty Enhancement and Reform Permanent Extension Act: This legislation strengthens public and private antitrust enforcement by providing incentives to antitrust violators to self-report the violations to the Justice Department and cooperate fully with government prosecutors and private litigants, as well as limiting the liability for civil damages claims in antitrust actions for a qualifying leniency applicant.
Criminal Antitrust Anti-Retaliation Act of 2019: This legislation would extend whistleblower protections and ensure greater accountability for criminal antitrust violations.
Congressman Neguse has also introduced the Merger Filing Fee Modernization Act which would ensure antitrust authorities have the resources they need to protect consumers.
- December 09, 2020
- December 08, 2020
- November 24, 2020
- October 07, 2020
- October 01, 2020
- September 16, 2020
- May 28, 2020